Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rivaroxaban Tablets

Approval Number

国药准字H20223318

Company北京百奥药业有限责任公司

Registration Date

May 18, 2022

Drug Information

Generic Name

利伐沙班片

Dosage Form

片剂

Strength

10mg

Drug Type

化学药品

Registration Date

May 18, 2022

Company Information

Applicant Company

Company Name北京百奥药业有限责任公司

Company Address

北京市昌平区科技园区超前路29号101室

Manufacturing Company

Company Name北京百奥药业有限责任公司

Company Address

北京市昌平区科技园区超前路29号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy